We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Strength Seen in Lemonade (LMND): Can Its 12.8% Jump Turn into More Strength?
Read MoreHide Full Article
Lemonade (LMND - Free Report) shares ended the last trading session 12.8% higher at $18.83. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 16.4% gain over the past four weeks.
Lemonade should continue gain from higher net added customers as well as expansion of geographic footprint. Higher prevalence of multiple policies per customer, growth in the overall average policy value and continued shift in the mix of underlying products toward higher value policies are likely to drive premium per customer year.
Lemonade boasts a solid capital position. Its existing cash and cash equivalents will be sufficient to meet working capital needs and capital expenditure over at least the next 12 months.
LMND has a track of meeting or outperforming its financial guidance for 10 consecutive quarters.
This company is expected to post quarterly loss of $1.17 per share in its upcoming report, which represents a year-over-year change of -2.6%. Revenues are expected to be $78.85 million, up 92.3% from the year-ago quarter.
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.
For Lemonade, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on LMND going forward to see if this recent jump can turn into more strength down the road.
Lemonade is a member of the Zacks Insurance - Multi line industry. One other stock in the same industry, Oscar Health, Inc. (OSCR - Free Report) , finished the last trading session 6.5% higher at $4.10. OSCR has returned 47% over the past month.
For Oscar Health, Inc., the consensus EPS estimate for the upcoming report has remained unchanged over the past month at -$1.01. This represents a change of -6.3% from what the company reported a year ago. Oscar Health, Inc. currently has a Zacks Rank of #3 (Hold).
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Strength Seen in Lemonade (LMND): Can Its 12.8% Jump Turn into More Strength?
Lemonade (LMND - Free Report) shares ended the last trading session 12.8% higher at $18.83. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 16.4% gain over the past four weeks.
Lemonade should continue gain from higher net added customers as well as expansion of geographic footprint. Higher prevalence of multiple policies per customer, growth in the overall average policy value and continued shift in the mix of underlying products toward higher value policies are likely to drive premium per customer year.
Lemonade boasts a solid capital position. Its existing cash and cash equivalents will be sufficient to meet working capital needs and capital expenditure over at least the next 12 months.
LMND has a track of meeting or outperforming its financial guidance for 10 consecutive quarters.
This company is expected to post quarterly loss of $1.17 per share in its upcoming report, which represents a year-over-year change of -2.6%. Revenues are expected to be $78.85 million, up 92.3% from the year-ago quarter.
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.
For Lemonade, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on LMND going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Lemonade is a member of the Zacks Insurance - Multi line industry. One other stock in the same industry, Oscar Health, Inc. (OSCR - Free Report) , finished the last trading session 6.5% higher at $4.10. OSCR has returned 47% over the past month.
For Oscar Health, Inc., the consensus EPS estimate for the upcoming report has remained unchanged over the past month at -$1.01. This represents a change of -6.3% from what the company reported a year ago. Oscar Health, Inc. currently has a Zacks Rank of #3 (Hold).